...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer.
【24h】

A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer.

机译:评估FDG-PET对食管癌基于CT的放射治疗计划的影响的前瞻性研究。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND AND PURPOSE: This prospective study sought to determine how the use of combined PET/CT for radiotherapy treatment planning of oesophageal cancer would alter the delineation of tumour volumes compared to CT alone if PET/CT is assumed to more accurately represent true disease extent. PATIENTS AND METHODS: All patients underwent FDG-PET/CT scanning in the radiotherapy treatment position. For each patient, two separate gross tumour volumes (GTV) were defined, one based on CT images alone (GTV-CT) and another based on combined PET/CT data (GTV-PET). Corresponding planning target volumes (PTV) were generated, and separate treatment plans were then produced. For each patient, volumetric analysis of GTV-CT, PTV-CT and GTV-PET was performed to quantify the proportion of PET-avid disease that was not included in the GTV and PTV (geographic miss) if CT data alone were used for radiotherapy planning. Assessment of the cranial and caudal extent of the primary oesophageal tumour as defined by CT alone vs PET/CT was also compared. RESULTS: The addition of PET information altered the clinical stage in 8 of 21 eligible patients enrolled on the study (38%); 4 patients had distant metastatic disease and 4 had unsuspected regional nodal disease. Sixteen patients proceeded to the radiotherapy planning phase of the study and received definitive chemoradiation planned with the PET/CT data set. The GTV based on CT information alone excluded PET-avid disease in 11 patients (69%), and in five patients (31%) this would have resulted in a geographic miss of gross tumour. The discordance between CT and PET/CT was due mainly to differences in defining the longitudinal extent of disease in the oesophagus. The cranial extent of the primary tumour as defined by CT vs PET/CT differed in 75% of cases, while the caudal extent differed in 81%. CONCLUSIONS: This study demonstrates that if combined PET/CT is used for radiotherapy treatment planning, there may be alterations to the delineation of tumour volumes when compared to CT alone, with the potential to avoid a geographic miss of tumour.
机译:背景与目的:这项前瞻性研究试图确定,如果假设PET / CT更准确地代表真实的疾病程度,那么与单独使用CT相比,将PET / CT联合用于食道癌的放射治疗计划将如何改变肿瘤体积的轮廓。患者与方法:所有患者均在放射治疗位置接受了FDG-PET / CT扫描。对于每位患者,定义了两个单独的总肿瘤体积(GTV),一个基于单独的CT图像(GTV-CT),另一个基于组合的PET / CT数据(GTV-PET)。生成了相应的计划目标量(PTV),然后制定了单独的治疗计划。对于每位患者,如果仅使用CT数据进行放射治疗,则对GTV-CT,PTV-CT和GTV-PET进行体积分析,以量化GTV和PTV(地理遗漏)中未包括的PET禽类疾病的比例规划。还比较了仅通过CT对比PET / CT对原发性食道肿瘤的颅骨和尾椎范围的评估。结果:PET信息的添加改变了参与研究的21例合格患者中的8例的临床分期(38%); 4例患者有远处转移病,4例患者未发现区域性淋巴结病。 16名患者进入了研究的放射治疗计划阶段,并接受了根据PET / CT数据集计划的确定性化学放射治疗。仅基于CT信息的GTV排除了11例患者(69%)的PET禽类疾病,而5例患者(31%)则导致了总体肿瘤的地理缺失。 CT和PET / CT之间的不一致主要是由于在定义食道疾病的纵向范围方面存在差异。 CT对PET / CT定义的原发肿瘤的颅骨范围在75%的病例中有所不同,而尾巴程度在81%的病例中却不同。结论:这项研究表明,如果将PET / CT组合用于放射治疗治疗计划,则与单独CT相比,可能会改变肿瘤体积的轮廓,并有可能避免肿瘤在地理上的遗漏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号